24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
DM · Super-Speciality (Medical)

Lung Cancer Thesis Topics for DM Medical Oncology — 59+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 59+ DM Medical Oncology (Lung Cancer) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

59+DM Medical Oncology (Lung Cancer) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 59 titles See a full thesis plan
Lung Cancer thesis topics

59 Lung Cancer thesis topics, by speciality

This page gathers the Lung Cancer titles in our catalogue, 59 in all, drawn from 10 specialities, so you can pick the angle your department supports. The commonest designs here are prospective observational study, retrospective record-based study, hospital-based cross-sectional study; 21 are marked High priority in our review.

DM Medical Oncology (Lung Cancer) — Thesis Title List

59 titles · instant objectives
  1. 001

    Concordance between PET-CT and EBUS-TBNA in mediastinal nodal staging of non-small cell lung cancer

    Lung Cancer & Interventional Pulmonology Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  2. 002

    Clinical and histological profile of lung cancer among never-smokers at a tertiary care centre

    Lung Cancer & Interventional Pulmonology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  3. 003

    Diagnostic delay in lung cancer and its association with prior empirical anti-tubercular treatment

    Lung Cancer & Interventional Pulmonology Hospital-based cross-sectional study Association / Correlation
    Objective
  4. 004

    EGFR mutation prevalence and its association with clinical characteristics in lung adenocarcinoma

    Lung Cancer & Interventional Pulmonology Hospital-based cross-sectional study Association / Correlation
    Objective
  5. 005

    EGFR mutation testing by real-time PCR in non-small cell lung carcinoma biopsies and its association with histological subtype and smoking

    Immunohistochemistry & Molecular Pathology Retrospective record-based study Association / Correlation
    Objective
  6. 006

    Subtyping of non-small cell lung carcinoma on image-guided FNAC using TTF-1 and p40 immunocytochemistry on cell blocks

    Cytopathology Prospective analytical study Diagnostic Accuracy
    Objective
  7. 007

    PD-L1 (22C3) tumour proportion score in non-small cell lung carcinoma biopsies and its association with histological subtype and EGFR mutation status

    Immunohistochemistry & Molecular Pathology Retrospective record-based study Association / Correlation
    Objective
  8. 008

    PD-L1 (22C3) immunocytochemistry on cell blocks of malignant pleural effusion in metastatic non-small cell lung carcinoma and its concordance with tissue biopsy

    Cytopathology Prospective analytical study Diagnostic Accuracy
    Objective
  9. 009

    Frequency of active tuberculosis detected by CBNAAT and liquid culture of respiratory specimens among patients with newly diagnosed lung carcinoma

    Mycobacteriology Prospective observational study Clinical Spectrum / Profile
    Objective
  10. 010

    Serum CYFRA 21-1, CEA and neuron-specific enolase panel in differentiating lung carcinoma from benign lung lesions

    Tumour Markers Hospital-based diagnostic study Diagnostic Accuracy Study
    Objective
  11. 011

    Clinico-pathological profile and EGFR/ALK mutation status in non-small cell lung cancer and response to targeted therapy

    Lung Cancer Prospective observational study Prospective Study
    Objective
  12. 012

    Response and survival with immune checkpoint inhibitors in advanced non-small cell lung cancer: a single-centre experience

    Lung Cancer Prospective observational study Prospective Study
    Objective
  13. 013

    Real-world outcomes and patterns of progression with first-line osimertinib in EGFR-mutant non-small cell lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  14. 014

    Response and toxicity of low-dose nivolumab with chemotherapy in advanced non-small cell lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  15. 015

    CT-defined sarcopenia and its association with chemotherapy toxicity in advanced lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  16. 016

    Prior empirical antitubercular treatment and diagnostic delay in patients with lung cancer

    Lung Cancer Hospital-based cross-sectional study Cross-sectional Study
    Objective
  17. 017

    Intracranial response to osimertinib in EGFR-mutant non-small cell lung cancer with brain metastases

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  18. 018

    Uptake, toxicity and early outcomes of perioperative and adjuvant systemic therapy in resectable non-small cell lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  19. 019

    Prevalence of KRAS G12C, ROS1, RET and MET exon 14 alterations on next-generation sequencing in EGFR- and ALK-negative non-small cell lung cancer

    Lung Cancer Hospital-based cross-sectional study Cross-sectional Study
    Objective
  20. 020

    Intrathecal pemetrexed in leptomeningeal metastases from non-small cell lung cancer: CSF cytological clearance, clinical response and myelosuppression

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  21. 021

    Segmentectomy versus lobectomy for early-stage non-small cell lung cancer: perioperative outcome and lung function

    Thoracic Oncology Prospective comparative study Comparative Study
    Objective
  22. 022

    Clinical, radiological and histopathological profile of primary lung cancer

    Respiratory Medicine Retrospective record-based study Clinical Spectrum / Profile
    Objective
  23. 023

    Adequacy of EBUS-TBNA samples for EGFR, ALK and PD-L1 testing in advanced non-small cell lung cancer

    Lung Cancer & Interventional Pulmonology Prospective observational study Diagnostic / Tool Evaluation
    Objective
  24. 024

    Prevalence of lung nodules on low-dose CT screening among high-risk smokers

    Lung Cancer & Interventional Pulmonology Prospective observational study Diagnostic / Tool Evaluation
    Objective
  25. 025

    Concordance of plasma cell-free DNA EGFR mutation testing with tissue testing in advanced non-small cell lung cancer

    Lung Cancer & Interventional Pulmonology Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  26. 026

    Progression-free survival and its predictors in EGFR-mutant non-small cell lung cancer on first-line tyrosine kinase inhibitors

    Lung Cancer & Interventional Pulmonology Prospective observational study Outcome / Prognostic
    Objective
  27. 027

    Clinical and molecular profile of lung cancer presenting with malignant pleural effusion

    Pleural Diseases Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  28. 028

    Stage at diagnosis and histological profile of lung cancer in women at a tertiary care centre

    Lung Cancer & Interventional Pulmonology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  29. 029

    Quality of life on EORTC QLQ-C30 and QLQ-LC13 in advanced lung cancer receiving first-line chemotherapy

    Lung Cancer & Interventional Pulmonology Prospective observational study Outcome / Prognostic
    Objective
  30. 030

    Incidental pulmonary nodules on chest CT and adherence to Fleischner Society follow-up recommendations

    Lung Cancer & Interventional Pulmonology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  31. 031

    Neutrophil-to-lymphocyte ratio as a prognostic marker in advanced non-small cell lung cancer

    Lung Cancer & Interventional Pulmonology Prospective observational study Outcome / Prognostic
    Objective
  32. 032

    Prevalence of hyponatraemia and its association with survival in lung cancer

    Lung Cancer & Interventional Pulmonology Prospective observational study Association / Correlation
    Objective
  33. 033

    Nutritional status by PG-SGA and its association with chemotherapy toxicity in lung cancer

    Lung Cancer & Interventional Pulmonology Prospective observational study Association / Correlation
    Objective
  34. 034

    Accuracy of staging EBUS-TBNA compared with postoperative pathological nodal staging in resectable non-small cell lung cancer

    Lung Cancer & Interventional Pulmonology Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  35. 035

    Frequency and characteristics of incidentally detected pulmonary embolism on contrast CT thorax performed for lung cancer staging

    Pulmonary Vascular Disease Retrospective record-based study Clinical Spectrum / Profile
    Objective
  36. 036

    CT morphological features of solitary pulmonary nodules and their correlation with histopathological diagnosis

    Chest Imaging Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  37. 037

    Thoracic ultrasound versus CT for assessing chest wall invasion in peripheral lung cancer with surgical correlation

    Chest Imaging Prospective observational study Diagnostic / Tool Evaluation
    Objective
  38. 038

    ALK D5F3 immunohistochemistry in lung adenocarcinoma and its concordance with fluorescence in situ hybridisation

    Immunohistochemistry & Molecular Pathology Retrospective record-based study Diagnostic Accuracy
    Objective
  39. 039

    TTF-1 and Napsin A immunohistochemistry in distinguishing primary lung adenocarcinoma from metastatic adenocarcinoma in lung biopsies

    Immunohistochemistry & Molecular Pathology Retrospective record-based study Diagnostic Accuracy
    Objective
  40. 040

    Spectrum of ocular adverse events in patients receiving EGFR tyrosine kinase inhibitors for lung cancer

    Systemic Disease & Eye Prospective observational study Descriptive Study
    Objective
  41. 041

    Clinical profile and outcome of lung cancer in never-smokers compared with smokers

    Lung Cancer Prospective comparative study Comparative Study
    Objective
  42. 042

    Clinical profile, treatment and survival in small cell lung cancer at a tertiary care centre

    Lung Cancer Retrospective record-based study Descriptive Study
    Objective
  43. 043

    Quality of life and symptom burden in patients with advanced lung cancer on systemic therapy

    Lung Cancer Prospective observational study Cross-sectional Study
    Objective
  44. 044

    PD-L1 expression and its correlation with response to immunotherapy in non-small cell lung cancer and urothelial carcinoma

    Immunotherapy & Targeted Therapy Prospective observational study Prospective Study
    Objective
  45. 045

    Concordance between plasma ctDNA and tissue testing for EGFR mutations in advanced non-small cell lung cancer

    Lung Cancer Prospective observational study Diagnostic Study
    Objective
  46. 046

    Outcome of alectinib in ALK-rearranged non-small cell lung cancer at a tertiary care centre

    Lung Cancer Prospective observational study Prospective Study
    Objective
  47. 047

    Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion in lung cancer

    Lung Cancer Prospective comparative study Comparative Study
    Objective
  48. 048

    Incidence and outcome of hyponatraemia due to SIADH in small cell lung cancer

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  49. 049

    Local consolidative therapy in oligometastatic non-small cell lung cancer: progression-free survival

    Metastatic Disease Prospective comparative study Comparative Study
    Objective
  50. 050

    Frequency of uncommon EGFR mutations and response to tyrosine kinase inhibitors in non-small cell lung cancer at a tertiary care centre

    Lung Cancer Retrospective record-based study Descriptive Study
    Objective
  51. 051

    Durvalumab consolidation after concurrent chemoradiation in unresectable stage III non-small cell lung cancer: progression-free survival and pneumonitis

    Lung Cancer Prospective observational study Prospective Study
    Objective
  52. 052

    Prevalence of cancer cachexia by international consensus criteria and its association with chemotherapy tolerance in advanced gastrointestinal and lung cancer

    Palliative & Supportive Care Hospital-based cross-sectional study Cross-sectional Study
    Objective
  53. 053

    Baseline pulmonary function and DLCO as predictors of radiation pneumonitis after concurrent chemoradiation in stage III non-small cell lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  54. 054

    Afatinib versus gefitinib or erlotinib as first-line therapy in EGFR exon 19 deletion or L858R non-small cell lung cancer: progression-free survival and toxicity

    Immunotherapy & Targeted Therapy Prospective comparative study Comparative Study
    Objective
  55. 055

    Local control and survival after gamma knife radiosurgery for brain metastases from lung cancer on targeted therapy

    Radiosurgery Prospective observational study Prospective Study
    Objective
  56. 056

    Outcome of lung resection for non-small cell lung cancer: VATS versus open lobectomy

    Thoracic Oncology Prospective comparative study Comparative Study
    Objective
  57. 057

    Systematic mediastinal lymph node dissection versus sampling in lung cancer: nodal upstaging

    Thoracic Oncology Prospective comparative study Comparative Study
    Objective
  58. 058

    Uniportal video-assisted thoracoscopic lobectomy for non-small cell lung cancer: lymph node yield, conversion and recovery

    Thoracic Oncology Prospective observational study Prospective Study
    Objective
  59. 059

    Short-term prehabilitation before lung cancer resection: change in six-minute walk distance and postoperative pulmonary complications

    Thoracic Oncology Prospective interventional study Interventional Study
    Objective

DM Medical Oncology (Lung Cancer) thesis — frequently asked questions

How many DM Medical Oncology (Lung Cancer) thesis topics are listed here?

59+ DM Medical Oncology (Lung Cancer) thesis topics are listed on this page, organised by subsection of the Medical Oncology (Lung Cancer) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Medical Oncology (Lung Cancer) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, DM and FCPS Medical Oncology (Lung Cancer) candidates?

Yes — these Medical Oncology (Lung Cancer) dissertation titles are aligned with NMC, NBE and DNB Medical Oncology (Lung Cancer) curricula and are suitable for DM Medical Oncology (Lung Cancer), DNB Medical Oncology (Lung Cancer) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp